Journal of drug assessment

Keyphrases

Publications

volume 12, number 1, 2022

Babafemi O Taiwo, Hela Romdhani, Marie-Hélène Lafeuille, Rhea Bhojwani, Katherine Milbers, Prina Donga
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews. Journal of drug assessment 12 (1) (2022)
Babafemi O Taiwo, Hela Romdhani, Marie-Hélène Lafeuille, Rhea Bhojwani, Katherine Milbers, Prina Donga
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews. Journal of drug assessment 12 (1) (2022)

volume 11, number 1, 2022

Crystal Watson, Hemanth Gadikota, Arie Barlev, Rachel Beckerman
A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen. Journal of drug assessment 11 (1) (2022)
Yue Zhang, Philippe Hubert, Cédric Hubert
Investigation of potential substandard dry powder inhalers on EU and North African markets - evaluation of the delivered and fine particle doses. Journal of drug assessment 11 (1) (2022)
Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman
Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea. Journal of drug assessment 11 (1) (2022)

volume 10, number 1, 2021

Blanca T Pacheco-Soto, Rebeca Garazi Elguezabal-Rodelo, Leonardo M Porchia, Enrique Torres-Rasgado, Ricardo Pérez-Fuentes, Martha Elba Gonzalez-Mejia
Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis. Journal of drug assessment 10 (1) (2021)
Beatriz Garcia-Cañibano, Sami Ouanes, Gowrii Saswathy Ganesan, Wajiha Yousuf, Basel Humos, Tehniyat Baig, Faiza Ibrahim, Rajvir Singh, Dirk Deleu
Real-world experience of ocrelizumab in multiple sclerosis in an Arab population. Journal of drug assessment 10 (1) (2021)
Stephen Z Molaoa
Prevalence of Helicobacter pylori infection and the incidence of the associated malignant and peptic ulcer disease (PUD) at Nelson Mandela Academic Hospital: a retrospective analysis. Journal of drug assessment 10 (1) (2021)
Rasha Kaddoura, Amr Elmoheen, Ehab Badawy, Mahmoud F Eltawagny, Mohamed A Seif, Khalid Bashir, Amar M Salam
Vasoactive pharmacologic therapy in cardiogenic shock: a critical review. Journal of drug assessment 10 (1) (2021)
Zumi Mehta, Khalid M Kamal, Richard Miller, Jordan R Covvey, Vincent Giannetti
Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database. Journal of drug assessment 10 (1) (2021)
Daniela Geba, Johan Mohd Sani, Michaela Gascon, Rebecca Hahn, Kavita Aggarwal, Jinky Rosselli
Hereditary angioedema patients would prefer newer-generation oral prophylaxis. Journal of drug assessment 10 (1) (2021)
Farzan Kianersi, Heshmatollah Ghanbari, Zahra Naderi Beni, Afsaneh Naderi Beni
Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy. Journal of drug assessment 10 (1) (2021)
Mohammad Pakravan, Afsaneh Naderi Beni, Shahin Yazdani, Hamed Esfandiari, Shahram Mirshojaee
Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma. Journal of drug assessment 10 (1) (2021)
Boulenouar Mesraoua, Bassel Abou-Khalil, Rola Hosni Khodair, Gayane Melikyan, Hassan Al Hail, Ali Akbar Asadi-Pooya
Seizure clusters. Journal of drug assessment 10 (1) (2021)

volume 10, number 1, 2020

Muhammad Maqsood, Muhammad Imran Hasan Khan, Mubashar Yameen, Kashif Aziz Ahmed, Nazim Hussain, Safdar Hussain
Use of oral rivaroxaban in cerebral venous thrombosis. Journal of drug assessment 10 (1) (2020)
Lisa M Hess, David Smith, Zhanglin L Cui, Leslie Montejano, Astra M Liepa, William Schelman, Lee Bowman
The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer. Journal of drug assessment 10 (1) (2020)
Lakyn Husinka, Pamela H Koerner, Rick T Miller, William Trombatt
Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer. Journal of drug assessment 10 (1) (2020)
Michael E Stuart, Sheri A Strite, Kristin Khalaf Gillard
A systematic evidence-based review of treatments for primary hyperhidrosis. Journal of drug assessment 10 (1) (2020)
Crystal Watson, Arie Barlev, Jodie Worrall, Steve Duff, Rachel Beckerman
Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients. Journal of drug assessment 10 (1) (2020)

volume 9, number 1, 2020

Enyew Getaneh Mekonen, Mignote Hailu Gebrie, Senetsehuf Melkamu Jemberie
Magnitude and associated factors of medication administration error among nurses working in Amhara Region Referral Hospitals, Northwest Ethiopia. Journal of drug assessment 9 (1) (2020)
Rasha Kaddoura, Bassant Orabi, Amar M Salam
Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and update. Journal of drug assessment 9 (1) (2020)
Marco Ometti, Davide Schipani, Pietro Conte, Pierluigi Pironti, Vincenzo Salini
The efficacy of intra-articular HYADD4-G injection in the treatment of femoroacetabular impingement: results at one year follow up. Journal of drug assessment 9 (1) (2020)
Beatriz Canibaño, Dirk Deleu, Boulenouar Mesraoua, Gayane Melikyan, Faiza Ibrahim, Yolande Hanssens
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations. Journal of drug assessment 9 (1) (2020)
David S Carrell, Ladia Albertson-Junkans, Arvind Ramaprasan, Grant Scull, Matt Mackwood, Eric Johnson, David J Cronkite, Andrew Baer, Kris Hansen, Carla A Green, Brian L Hazlehurst, Shannon L Janoff, Paul M Coplan, Angela DeVeaugh-Geiss, Carlos G Grijalva, Caihua Liang, Cheryl L Enger, Jane Lange, Susan M Shortreed, Michael Von Korff
Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: development and evaluation of an algorithm for use in EHR and claims data. Journal of drug assessment 9 (1) (2020)
Matteo Vitali, Marco Ometti, Andreas Drossinos, Pierluigi Pironti, Luca Santoleri, Vincenzo Salini
Autologous conditioned serum: clinical and functional results using a novel disease modifying agent for the management of knee osteoarthritis. Journal of drug assessment 9 (1) (2020)
Aleksandar R Peric, Sandra Vezmar Kovačević, Aleksandra Barać, Dejan Gaćeša, Aneta V Perić, Danilo Vojvodić
Effects of Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitis. Journal of drug assessment 9 (1) (2020)
Steven Deitelzweig, Christine L Baker, Amol D Dhamane, Jack Mardekian, Oluwaseyi Dina, Lisa Rosenblatt, Cristina Russ, Tayla Poretta, Melissa Lingohr-Smith, Jay Lin
Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States. Journal of drug assessment 9 (1) (2020)
László Kardos
Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data? Journal of drug assessment 9 (1) (2020)
Ioannis Stavropoulos, Angelos Sarantopoulos, Anastasios Liverezas
Does sympathetic nervous system modulate tumor progression? A narrative review of the literature. Journal of drug assessment 9 (1) (2020)
Seyed MohammadReza Hashemian, Tayebeh Farhadi
A review on modafinil: the characteristics, function, and use in critical care. Journal of drug assessment 9 (1) (2020)
Yogita Tyagi, Nv Satheesh Madhav
Inbuilt novel bioretardant feature of biopolymer isolated from cucumis sativa for designing drug loaded bionanosuspension. Journal of drug assessment 9 (1) (2020)
María Del Pino Cidad-Betegón, Félix Armadá-Maresca, Gloria Amorena-Santesteban, Javier Coca-Robinot, Oriana D'Anna-Mardero, Irene de la Rosa-Pérez, Beatriz Manzano-Muñoz, Jesús García-Martínez, Mónica Asencio-Durán, Gema Casado-Abad
Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting? Journal of drug assessment 9 (1) (2020)
Zinat Farhadi, Tayebeh Farhadi, Seyed MohammadReza Hashemian
Virtual screening for potential inhibitors of β(1,3)-D-glucan synthase as drug candidates against fungal cell wall. Journal of drug assessment 9 (1) (2020)
Hema Jagannathan, Amulya Thota, Ashok Kumar B Kumarappa, Githa Kishore
A comparative study of aceclofenac versus etoricoxib in the management of acute low back pain in a tertiary care hospital. Journal of drug assessment 9 (1) (2020)
Danesh Alam, Carlos Tirado, Mark Pirner, Thomas Clinch
Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials. Journal of drug assessment 9 (1) (2020)
Antti Valtola, James Denzil Morse, Pawel Florkiewicz, Heidi Hautajärvi, Pasi Lahtinen, Tadeusz Musialowicz, Brian Joseph Anderson, Veli-Pekka Ranta, Hannu Kokki
Bioavailability of oxycodone by mouth in coronary artery bypass surgery patients - a randomized trial. Journal of drug assessment 9 (1) (2020)

volume 9, number 1, 2019

Jil Mamza, Uchena Anyanwagu, Mohammed Alkharaiji, Iskandar Idris
Clinical characteristics and patient treatment satisfaction with Humalog U-200 in patients with type 2 diabetes mellitus: an observational study. Journal of drug assessment 9 (1) (2019)
Chin-Yao Chou, Yu-Jang Su, Hsiu-Wu Yang, Chen-Wang Chang
Risk factors for mortality in emphysematous pancreatitis. Journal of drug assessment 9 (1) (2019)

volume 8, number 1, 2019

Sibel Çağlar, Meltem Vural, Yasemin Pekin Doğan, Murat Mert, Nil Sayıner Çağlar
The effect of pregabalin treatment on balance and gait in patients with chronic low back pain: a retrospective observational study. Journal of drug assessment 8 (1) (2019)
Paolo Barone, Angelo Antonini, Paolo Stanzione, Karin Annoni, Mahnaz Asgharnejad, Ubaldo Bonuccelli
Risk factors for impulse control disorders and related behaviors in Parkinson's disease: secondary analyses of the ICARUS study. Journal of drug assessment 8 (1) (2019)
Alessandro Battaggia, Andrea Scalisi, Francesco Magliozzo, Bruno Novelletto Franco, Massimo Fusello, Raffaella Michieli, Maurizio Cancian
The burden of frailty in older people visiting GPs in Veneto and Sicily, Italy. Journal of drug assessment 8 (1) (2019)
Gordon Liu, Jason Shepherd, Pratik Rane, Zhongyun Zhao, Hollie Bailey, Nathan Williams, Yi Qian
Characteristics of patients with dyslipidemia treated in routine care setting in China. Journal of drug assessment 8 (1) (2019)
Matteo Vitali, Nadim Naim Rodriguez, Pierluigi Pironti, Andreas Drossinos, Gaia Di Carlo, Anshuman Chawla, Fraschini Gianfranco
ESWT and nutraceutical supplementation (Tendisulfur Forte) vs ESWT-only in the treatment of lateral epicondylitis, Achilles tendinopathy, and rotator cuff tendinopathy: a comparative study. Journal of drug assessment 8 (1) (2019)
Zarina Brady, Zhivka Stoykova
Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria. Journal of drug assessment 8 (1) (2019)
Pedro Sánchez-Rovira, Pilar Zamora, Javier Salvador-Bofill, Serafín Morales, Noelia Martínez-Jáñez, Eduardo Martínez-de-Dueñas, Ana Lluch, José Juan Illarramendi, Patricia Gómez-Pardo, Joaquín Gavilá Gregori, Andrés García-Palomo, Jesús García-Mata, Yolanda Fernández, Sonia Del Barco, Ana de Juan, Eva Ciruelos, José Ignacio Chacón, Lourdes Calvo, Agustí Barnadas, Joan Albanell
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists. Journal of drug assessment 8 (1) (2019)
Sergei A Tjulandin, Alexey A Tryakin, Natalia S Besova, Evgeniya Sholokhova, Jasmina I Ivanova, Wendy Y Cheng, Luke M Schmerold, Philippe Thompson-Leduc, Diego Novick
Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study. Journal of drug assessment 8 (1) (2019)
Genevieve Gauthier, Lisa Mucha, Sherry Shi, Annie Guerin
Economic burden of relapse/recurrence in patients with major depressive disorder. Journal of drug assessment 8 (1) (2019)
Elżbieta Kowalska-Olędzka, Magdalena Czarnecka, Anna Baran
Epidemiology of atopic dermatitis in Europe. Journal of drug assessment 8 (1) (2019)
Michael S Kostapanos, Paul J Cacciottolo, Annette Hubsch, Holly Pavey, James Hurlock, Kaisa Maki-Petaja, Ian B Wilkinson, Joseph Cheriyan
Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers - a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale. Journal of drug assessment 8 (1) (2019)
T Gold, Setareh A Williams, Richard J Weiss, Yamei Wang, Christopher Watkins, James Carroll, Chloe Middleton, Stuart Silverman
Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey. Journal of drug assessment 8 (1) (2019)